British Journal of Oral and Maxillofacial Surgery
Volume 46, Issue 2 , Pages 90-95, March 2008

Oral mucosal diseases: Erythema multiforme

  • Crispian Scully

      Affiliations

    • University College London, Eastman Dental Institute, UK
    • Corresponding Author InformationCorresponding author at: Eastman Dental Institute, University College London, 256 Gray's Inn Road, London WC1X 8LD, UK. Tel.: +44 20 7915 1038; fax: +44 20 7915 1039.
  • ,
  • Jose Bagan

      Affiliations

    • Service of Stomatology, University General Hospital, Valencia, Spain

Accepted 19 July 2007. published online 03 September 2007.

Abstract 

Erythema multiforme (EM) is a rare acute mucocutaneous condition caused by a hypersensitivity reaction with the appearance of cytotoxic T lymphocytes in the epithelium that induce apoptosis in keratinocytes, which leads to satellite cell necrosis. EM can be triggered by a range of factors, but the best documented association is with preceding infection with herpes simplex virus (HSV). Most other cases are initiated by drugs.

EM has been classified into a number of variants, mainly minor and major forms, as it may involve the mouth alone, or present as a skin eruption with or without oral or other lesions of the mucous membrane. EM minor typically affects only one mucosa, and may be associated with symmetrical target skin lesions on the extremities. EM major typically involves two or more mucous membranes with more variable skin involvement. A severe variant of EM major is Stevens–Johnson syndrome, which typically extensively involves the skin. Both EM major and Stevens–Johnson syndrome can involve internal organs and produce systemic symptoms.

Treatment of EM is controversial, as there is no reliable evidence. Precipitants should be avoided or treated and, in severe cases, corticosteroids may be needed.

Toxic epidermal necrolysis may be similar to Stevens–Johnson syndrome, but many experts regard it as a discrete disease, and therefore it is not discussed here.

Keywords: Erythema multiforme, Autoimmune, Immunosuppressants, Oral, Vesiculobullous, Skin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0266-4356(07)00376-2

doi:10.1016/j.bjoms.2007.07.202

British Journal of Oral and Maxillofacial Surgery
Volume 46, Issue 2 , Pages 90-95, March 2008